Premium
FN1: A novel fusion partner of ALK in an inflammatory myofibroblastic tumor
Author(s) -
Ouchi Kazutaka,
Miyachi Mitsuru,
Tsuma Yusuke,
Tsuchiya Kunihiko,
Iehara Tomoko,
Konishi Eiichi,
Yanagisawa Akio,
Hosoi Hajime
Publication year - 2015
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.25424
Subject(s) - anaplastic lymphoma kinase , fusion gene , medicine , cancer research , pathology , gene , lung cancer , biology , genetics , malignant pleural effusion
Inflammatory myofibroblastic tumors (IMTs) are rare tumors characterized as low‐to‐intermediate grade sarcomas. Rearrangements of the anaplastic lymphoma kinase ( ALK ) gene have been reported in IMT. Here, we describe a novel fusion gene in an IMT tumor specimen. A 12‐year‐old male was admitted to our hospital with a bladder tumor. We identified the fibronectin 1 gene ( FN1 ) as a fusion partner of ALK using 5′RACE. This novel fusion, FN1–ALK , resulted in ALK overexpression in the IMT. This finding should clarify the causes of IMT and facilitate development of novel therapeutics. Pediatr Blood Cancer 2015;62:909–911. © 2015 Wiley Periodicals, Inc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom